Alterity Therapeutics
$3.56
25
-$0.08-2.22% Thursday 19:57
Statistics
Day High
3.6
Day Low
3.49
52W High
7
52W Low
2.52
Volume
2,828
Avg. Volume
12,281
Mkt Cap
38.67B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
25FebExpected
Expected EPS
-0.0005389060173610135
Actual EPS
-0.000843505070652021
Financials
-Profit Margin
Unprofitable0Revenue
-15.7MNet Income
Analyst Ratings
$0.00Average Price Target
The highest estimate is 0.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy 0%
Hold 100%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ATHE. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap22.63B
Palatin Technologies
PTN
Mkt Cap2.45M
Acadia Pharmaceuticals
ACAD
Mkt Cap3.83B
AnaptysBio
ANAB
Mkt Cap1.02B
Anavex Life Sciences
AVXL
Mkt Cap684.57M
Axsome Therapeutics
AXSM
Mkt Cap6.74B
Ionis Pharmaceuticals
IONS
Mkt Cap12.03B
Prothena
PRTA
Mkt Cap578.67M
Voyager Therapeutics
VYGR
Mkt Cap259.04M
About
Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that is in Phase I clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy advance; and PBT2 that has completed Phase 2a clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.
Show more...
CEO
Mr. Geoffrey Paul Kempler B.Sc.
Employees
10
Country
AU
ISIN
US02155X2053
Listings
0 Comments
Share your thoughts
FAQ
What is Alterity Therapeutics stock price today?▼
The current price of ATHE is $3.56 USD — it has decreased by -2.22% in the past 24 hours. Watch Alterity Therapeutics stock price performance more closely on the chart.
What is Alterity Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Alterity Therapeutics stocks are traded under the ticker ATHE.
Is Alterity Therapeutics stock price growing?▼
ATHE stock has risen by +12.51% compared to the previous week, the month change is a +4.57% rise, over the last year Alterity Therapeutics has showed a +21.22% increase.
What is Alterity Therapeutics market cap?▼
Today Alterity Therapeutics has the market capitalization of 38.67B
When is the next Alterity Therapeutics earnings date?▼
Alterity Therapeutics is going to release the next earnings report on August 28, 2026.
What were Alterity Therapeutics earnings last quarter?▼
ATHE earnings for the last quarter are -0 USD per share, whereas the estimation was -0 USD resulting in a -56.52% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Alterity Therapeutics revenue for the last year?▼
Alterity Therapeutics revenue for the last year amounts to 0 USD.
What is Alterity Therapeutics net income for the last year?▼
ATHE net income for the last year is -15.7M USD.
How many employees does Alterity Therapeutics have?▼
As of April 03, 2026, the company has 10 employees.
In which sector is Alterity Therapeutics located?▼
Alterity Therapeutics operates in the Health Care sector.
When did Alterity Therapeutics complete a stock split?▼
The last stock split for Alterity Therapeutics was on January 09, 2023 with a ratio of 1:10.
Where is Alterity Therapeutics headquartered?▼
Alterity Therapeutics is headquartered in Melbourne, AU.